Active Ingredient(s):Azilsartan Medoxomil + Chlorthalidone FDA Approved: * December 20, 2011 Pharm Company: *TAKEDA PHARMS NA Category:Blood Pressure
Azilsartan is an angiotensin II receptor antagonist used in the treatment of hypertension, developed by Takeda. It is marketed in tablet form under the brand name Edarbi as the prodrug azilsartan medoxomil.
The most common adverse reaction in adults is diarrhea.
It is also sold as a combination drug with chlortalidone under the brand name Edarbyclor.
1 Structure activit...
* May have multiple approval dates, manufacturers, or labelers. 6 Discussions